Saatchi reportedly wins Levitra DTC work

Share this article:

The Saatchi & Saatchi Consumer Healthcare unit of Publicis Groupe has won the creative duties for Levitra, AdWeek.com reported late Thursday.
Levitra, which is now co-promoted by Schering-Plough and GlaxoSmithKline, has been in review for the past several weeks.
CommonHealth's Quantum previously held the account, but was not listed among the groups who were pitching. A spokeswoman for CommonHealth declined to comment to MM&M about the review this week
Estimated billings are $90 million.
The other finalists were Omnicom Group shops BBDO and Merkley + Partners, both in New York, according to AdWeek. DDB, another Omnicom shop, initially pursued the business but withdrew before final presentations, the report stated.
Bayer and GSK co-promoted Levitra since its launch in 2003, but earlier this year Bayer agreed to turn over marketing rights for most of its prescription drug products to Schering-Plough.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.